2022 / 05

Next Paper
DOI: 10.24075/brsmu.2022.055

ORIGINAL RESEARCH

Frequent association of vitiligo with autoimmune endocrine diseases: primary data of the Russian cohort of adult patients

Nuralieva NF1, Yukina MYu1, Troshina EA1, Zhukova OV2,3, Petrov VA2, Volnukhin VA2
About authors

1 Endocrinology Research Centre, Moscow, Russia

2 Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia

3 Peoples’ Friendship University of Russia, Moscow, Russia

Correspondence should be addressed: Nurana F. Nuralieva
Dmitriya Ulyanova, 11, Moscow, 117292, Russia; ur.xednay@anarunn

About paper

Funding: this work was supported by Foundation for Scientific and Technological Development of Yugra (agreement No 2022-05-01/2022).

Author contribution: Nuralieva NF — endocrinology examination, data acquisition, statistical analysis, literature analysis, manuscript writing, preparation of the article for publication; Yukina MYu — study concept development, endocrinology examination, manuscript editing; Troshina EA — approval of the study concept and the final text of the manuscript; Zhukova OV — approval of the final text of the manuscript; Petrov VA — dermatology examination, data acquisition, literature analysis; Volnukhin VA — approval of the study concept, dermatology examination, manuscript editing and approval of the final text.

Compliance with ethical standards: the study was approved by the Ethics Commitee of the Endocrinology Research Centre (protocol № 17 of 27 September 2017); the informed consent was submitted by all patients.

Received: 2022-09-29 Accepted: 2022-10-13 Published online: 2022-10-29
|
  1. Amerio P, Di Rollo D, Carbone A, Auriemma M, Marra ME, De Remigis P, et al. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol. 2010; 20 (3): 354–8. DOI: 10.1684/ ejd.2009.0939.
  2. Hansen MP, Matheis N, Kahaly GJ. Type 1 diabetes and polyglandular autoimmune syndrome: A review. World J Diabetes. 2015; 6 (1): 67–79. DOI: 10.4239/wjd.v6.i1.67.
  3. Perheentupa J. Autoimmune Polyendocrinopathy-CandidiasisEctodermal Dystrophy. J Clin Endocrinol Metab. 2006; 91 (8): 2843–50. DOI: 10.1210/jc.2005-2611.
  4. Van Geel N, Speeckaert M, Brochez L, Lambert J, Speeckaert R. Clinical profile of generalized vitiligo patients with associated autoimmune/autoinflammatory diseases. J Eur Acad Dermatol Venereol. 2014; 28 (6): 741–6. DOI: 10.1111/jdv.12169.
  5. Korkij W, Solatani K, Simjee S, Marcincin PG, Chuang TY. Tissuespecific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study. J Cutan Pathol. 1984; 11 (6): 522–30. DOI: 10.1111/j.1600-0560.1984.tb00413.x.
  6. Yuan J, Sun C, Jiang S, Lu Y, Zhang Y, Gao X-H, et al. The prevalence of thyroid disorders in patients with vitiligo: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2019; 9: 803. DOI: 10.3389/fendo.2018.00803.
  7. Fan KC, Yang TH, Huang YC. Vitiligo and thyroid disease: a systematic review and meta-analysis. Eur J Dermatol. 2018; 28 (6): 750–63. DOI: 10.1684/ejd.2018.3449.
  8. Gey A, Diallo A, Seneschal J, Léauté-Labrèze C, Boralevi F, Jouary T, et al. Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms. Br J Dermatol. 2013; 168 (4): 756–61. DOI: 10.1111/bjd.12166.
  9. Chen Y, Chen Y, Hwang C, Lin MW, Chen TJ, Chen CC, et al. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan. J Eur Acad Dermatol Venereol. 2015; 29 (7): 1362–9. DOI: 10.1111/jdv.12870.
  10. Lazzeri L, Colucci R, Cammi A, Dragoni F, Moretti S. Adult onset vitiligo: multivariate analysis suggests the need for a thyroid screening. Biomed Res Int. 2016; 2016: 1–5. DOI: 10.1155/2016/8065765.
  11. Ingordo V, Cazzaniga S, Raone B, Digiuseppe MD, Musumeci ML, Fai D, et al. Circulating Aautoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study. Dermatology. 2014; 228 (3): 240–9. DOI: 10.1159/000357807.
  12. Kumar K, Priya S, Sharma R, Kapoor U, Saini M, Bisht YS. Autoimmune thyroid disease in patients with vitiligo: prevalence study in India. Endocr Pract. 2012; 18 (2): 194–9. DOI: 10.4158/ EP11205.OR.
  13. Akay BN, Bozkir M, Anadolu Y, Gullu S. Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey. J Eur Acad Dermatol Venereol. 2010; 24 (10): 1144–50. DOI: 10.1111/j.14683083.2010.03605.x.
  14. Bae J, Lee J, Yun J, Han B, Han TY. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea. J Am Acad Dermatol. 2017; 76 (5): 871–8. DOI: 10.1016/j.jaad.2016.12.034.
  15. Hegedus L, Heidenheim M, Gervil M, Hjalgrim H, HøierMadsen M. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol. 1994; 74 (2): 120–3. DOI: 10.2340/0001555574120123.
  16. Poojary S. Vitiligo and associated autoimmune disorders: A retrospective hospital-based study in Mumbai, India. Allergol Immunopathol (Madr). 2011; 39 (6): 356–61. DOI: 10.1016/j. aller.2010.12.007.
  17. Sivasubramanian A, Ganapathi S. The study on association of co-morbidities in female patients with vitiligo. Int J Res Dermatol. 2019; 5 (1): 203. DOI: 10.18203/issn.2455–4529.
  18. Liu CW, Huang YC. Vitiligo and autoantibodies: a systematic review and meta-analysis. J Dtsch Dermatol Ges. 2018; 16 (7): 845–51. DOI: 10.1111/ddg.13574.
  19. Laberge G, Mailloux C, Gowan K, Holland P, Bennett DC, Fain PR, et al. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 2005; 18 (4): 300–5. DOI: 10.1111/j.1600-0749.2005.00242.x.
  20. Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010; 123 (2): 183.e1–9. DOI:10.1016/j.amjmed.2009.06.030.
  21. Ruggeri R, Trimarchi F, Giuffrida G, Certo R, Cama E, Campennì A, et al. Autoimmune comorbidities in Hashimoto’s thyroiditis: different patterns of association in adulthood and childhood/adolescence. Eur J Endocrinol. 2017; 176 (2): 133–41. DOI: 10.1530/EJE-160737.
  22. Ferrari S, Fallahi P, Ruffilli I, Elia G, Ragusa F, Benvenga S, et al. The association of other autoimmune diseases in patients with Graves' disease (with or without ophthalmopathy): Review of the literature and report of a large series. Autoimmun Rev. 2019; 18 (3): 287–92. DOI: 10.1016/j.autrev.2018.10.001.
  23. Nederstigt C, Uitbeijerse B, Janssen L, Corssmit EPM, de Koning EJP, Dekkers OM. Associated autoimmune disease in type 1 diabetes patients: a systematic review and meta-analysis. Eur J Endocrinol. 2019; 180 (2): 135–44. DOI: 10.1530/EJE-18-0515.
  24. Ferre E, Rose S, Rosenzweig S, Burbelo PD, Romito KR, Niemela JE, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016; 1 (13): e88782. DOI: 10.1172/jci.insight.88782.
  25. Nicolaidou E, Antoniou C, Miniati A, Lagogianni E, Matekovits A, Stratigos A, et al. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics. J Am Acad Dermatol. 2012; 66 (6): 954–8. DOI: 10.1016/j.jaad.2011.07.010.
  26. Turiev GS. Autoimmunnye zabolevaniya u bol'nyx saxarnym diabetom vzroslyx. Vladikavkazskij mediko-biologich. vestn. 2013; 17 (26): 74–80. Russian.
  27. Lomonosov KM, Simonova NI, Lomonosov MK. Sravnitel'nyj analiz syvorotochnogo soderzhaniya autoantitel u bol'nyx vitiligo. Ros. zhurn. kozhnyx i venericheskix boleznej. 2013; 2: 35. Russian.
  28. Agarwala S, Malkud S. A study on the clinico-epidemiological profile of vitiligo patients and its association with endocrine, audiological and ocular abnormalities. Iran J Dermatol. 2020; 23: 155–162. DOI: 10.22034/ijd.2020.120835.
  29. Carstensen B, Rønn PF, Jørgensen ME. Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996– 2016. BMJ Open Diabetes Res Care. 2020; 8 (1): e001071. DOI: 10.1136/bmjdrc-2019-001071.
  30. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev. 2002; 23 (3): 327–364. DOI: 10.1210/er.23.3.327.